These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene. Wang X, Chen S, Burtscher I, Sterr M, Hieronimus A, Machicao F, Staiger H, Häring HU, Lederer G, Meitinger T, Lickert H. Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211 [Abstract] [Full Text] [Related]
3. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. Wang X, Sterr M, Burtscher I, Chen S, Hieronimus A, Machicao F, Staiger H, Häring HU, Lederer G, Meitinger T, Cernilogar FM, Schotta G, Irmler M, Beckers J, Hrabě de Angelis M, Ray M, Wright CVE, Bakhti M, Lickert H. Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371 [Abstract] [Full Text] [Related]
4. Point mutations in the PDX1 transactivation domain impair human β-cell development and function. Wang X, Sterr M, Ansarullah, Burtscher I, Böttcher A, Beckenbauer J, Siehler J, Meitinger T, Häring HU, Staiger H, Cernilogar FM, Schotta G, Irmler M, Beckers J, Wright CVE, Bakhti M, Lickert H. Mol Metab; 2019 Jun; 24():80-97. PubMed ID: 30930126 [Abstract] [Full Text] [Related]
5. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1. Pires C, Schmid B, Petræus C, Poon A, Nimsanor N, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Hyttel P, Freude KK. Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212 [Abstract] [Full Text] [Related]
8. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene. Galera-Monge T, Zurita-Díaz F, Moreno-Izquierdo A, Fraga MF, Fernández AF, Ayuso C, Garesse R, Gallardo ME. Stem Cell Res; 2016 May; 16(3):673-6. PubMed ID: 27346197 [Abstract] [Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Hyttel P, Freude KK. Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973 [Abstract] [Full Text] [Related]
10. Generation of a human iPSC line from a patient with a defect of intergenomic communication. Zurita F, Galera T, González-Páramos C, Moreno-Izquierdo A, Schneiderat P, Fraga MF, Fernández AF, Garesse R, Gallardo ME. Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795 [Abstract] [Full Text] [Related]
12. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1. Tubsuwan A, Pires C, Rasmussen MA, Schmid B, Nielsen JE, Hjermind LE, Hall V, Nielsen TT, Waldemar G, Hyttel P, Clausen C, Kitiyanant N, Freude KK, Holst B. Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792 [Abstract] [Full Text] [Related]
13. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1. Jung-Klawitter S, Ebersold J, Göhring G, Blau N, Opladen T. Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739 [Abstract] [Full Text] [Related]
14. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC. Jung-Klawitter S, Blau N, Sebe A, Ebersold J, Göhring G, Opladen T. Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587 [Abstract] [Full Text] [Related]
15. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2. Fatima A, Ivanyuk D, Herms S, Heilmann-Heimbach S, O'Shea O, Chapman C, Izsvák Z, Farr M, Hescheler J, Šarić T. Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990 [Abstract] [Full Text] [Related]
16. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T. Ma D, Ng SH, Zeng L, Zhao Y, Tan EK. Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805 [Abstract] [Full Text] [Related]
17. Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia. Nimsanor N, Jørring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Kitiyanant N, Nielsen JE, Nielsen TT, Hyttel P, Holst B, Schmid B. Stem Cell Res; 2016 Nov; 17(3):564-567. PubMed ID: 27789411 [Abstract] [Full Text] [Related]
18. Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene. Zurita-Díaz F, Galera-Monge T, Moreno-Izquierdo A, Fraga MF, Ayuso C, Fernández AF, Garesse R, Gallardo ME. Stem Cell Res; 2016 Jan; 16(1):124-7. PubMed ID: 27345796 [Abstract] [Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5). Hauser S, Höflinger P, Theurer Y, Rattay TW, Schöls L. Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220 [Abstract] [Full Text] [Related]
20. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5). Höflinger P, Theurer Y, Schüle R, Schöls L, Hauser S. Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]